Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Effects of Bogijetong-Tang on Diabetic-peripheral Neuropathy Induced by Streptozotocin in the Mouse

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2013, v.34 no.3, pp.126-142



  • Downloaded
  • Viewed

Abstract

Objectives: Previous reports have shown that Bogijetong-Tang (BJT) is effective in peripheral neuropathy induced by taxol and crush injury. In this study, we researched the effects of BJT on diabetic neuropathy induced by STZ in the mouse. Methods: We performed both in vitro and in vivo experiments to verify the effects of BJT on diabetic neuropathy induced by STZ in mice. Changes in axonal recovery were observed with immunofluorescence staining using NF-200, Hoechst33258, S100β, caspase 3 and anti-cdc2. Proliferation and degeneration of Schwann cells were investigated by immunofluorescence staining and western blot analyses. Results: BJT showed considerable effects on neurite outgrowth and axonal regeneration in diabetic neuropathy. BJT contributed to the creation of NF-200, GAP-43, Cdc2, phospho-vimentin, β1, active β1, β3 integrin, phospho-Erk1/2 protein. Conclusions: Through this study, we found that BJT is effective for enhanced axonal regeneration via dynamic regulation of regeneration-associated proteins. Therefore, BJT had a pharmaceutical property enhancing recovery of peripheral nerves induced by diabetic neuropathy and could be a candidate for drug development after more research.

keywords
Diabetic-peripheral neuropathy, Bogijetong-Tang (BJT), sciatic nerve, Schwann cell, dorsal root ganglia


Reference

1

1. The Whole Country College Korean Medicine,Department of Singye Internal Medicine. SingyeInternal Medicine. Seoul:Koonja publishing co..2011:310.

2

2. Shaw JE, Zimmet PZ. The epidemiology of diabeticneuropathy. Diabetes. 1999;7:245-52.

3

3. Kathleen M, Halat, Cathi E, Dennehy, Pharm D.Botanicals and Dietary Supplements in DiabeticPeripheral Neuropathy. J Am Board Fam Pract.2003;16(1):47-57.

4

4. Kinoshita JH, Nishimura C. The involvement of aldosereductase in diabetic complications. DiabetesMetab. 1988;4:323-37.

5

5. Kaul CL, Ramarao P. The role of aldose reductaseinhibitions in diabetic complications: recent trends.Methods Find Exp Clin Phamacol. 2001;23:465-75.

6

6. Green DA, Lattimer SA, Sima AF. Sorbitol, phosphoinositides and sodium-potassium ATPase in the pathogenesisof diabetic complication. The New EnglandJournal of medicine. 1987;316(10):599-606.

7

7. Dyck PJ. Detection, characterization and staging ofpolyneuropathy: assessed in diabetes. Muscle &Nerve. 1988;11(1):21-32.

8

8. Kim JM, Cho CS, Kim CJ. Overview of DiabeticPeripheral Neuropathy and Need for TherapeuticStrategy using Traditional Korean Medicine. J KoreanOriental Med. 2009:30(5)127-36.

9

9. Chen YS. Wu CH,YAO CH, Chen CT. GinsenosideRb-1 enhance peripheral nerve regeneration acrosswide gaps in silicone rubber chambers. Int J ArtifOrgan. 2002;Nov;25(11):1103-8.

10

10. Korean Diabetes Association, Group forResearch on Neuropathy. Diabetic Neuropathy.Seoul:Gold Gihoek. 2006:172-3.

11

11. Kang SB. 2 case of Diabetic NeuropathyTreatments. J Korean Oriental Med. 1992;13(2):22-5.

12

12. Park SW, Kang JK, Moon SK, Ko CN. Two experiencesof the treatment for diabetic peripheralneuropathy. Journal of Korean Oriental ChronicDisease. 1997;3(1):251-8.

13

13. Cho KH, Jung S, Lee KJ. A Case ofYukmijihwanghwan's effect on Diabeticneuropathy. Korean J. Orient. Int. Med. 1999;20(1):286-90.

14

14. Kwon YK, Choi KR, Lee JS, Lee BC, Ahn YM,Ahn SY, et al. Two Cases of Diabetic PeripheralPolyneuropathy Improved by Bogan-tang. JKorean Oriental Med. 2002;23(1):170-7.

15

15. Park SK, Kwon EH, Shin HC, Kang SB. Onecase of Diabetic Peripheral PolyneuropathyImproved by Binsosan-gamibang. J KoreanOriental Med. 2005:26(4):935-40.

16

16. Choi HS, Cho CS, Kim CJ. Clinical Study onTwo Cases of In patients with DiabeticPeripheral Neuropathy. Daejeon UniversityInstitute of korean medicine thesis Collection.2004;13(2)251-8.

17

17. Kim JM, Cho CS, Kim CJ.. Clinical Study of8 Diabetic Patients with Paresthesia. Korean J.Orient. Int. Med. 2010:31(2)184-91.

18

18. An SH. Effects of Bogijetong-tang treatment onanimal model of peripheral neuropathy inducedby Taxol and crush injury. Doctoral Dissertation.Daejeon:Daejeon Univ.;2012.

19

19. Banker G, Goslin K. Culturing nerve cells. MITpress. 2002.

20

20. Felderman EL, Russell JW, Sullivan KA,Golovoy D. New insights into the pathogenesisof diabetic neuropathy. Curr Opin Neurol. 1999;12:553-63.

21

21. Verrotti A, Giuva PT, Morgese G, Chiarelli F.New trends in the etiopathogenesis of diabeticperipheral neuropathy. J Child Neurol. 2001;16:389-94.

22

22. Stevens MJ, Felderman EL, Greene DA. Theaetiology of diabetic neuropathy: the combinedroles of metabolic and vascular defects. DiabetMed. 1995;12:566-79.

23

23. Greene DA, Lewis RA, Lattimer SA, Brown MJ.Selective effects of myo-inositol administrationon sciatic and tibial motor nerve conduction parametersin the streptozocin-diabetic rat.Diabetes. 1982;31:573-8.

24

24. Greene DA, Sima AA, Stevens MJ, FeldermanEL, Lattimer SA. Complication: neuropathy,pathogenetic consideration. Diabetes Cares.1992;15:1902-25.

25

25. Brownlee M, Vlassara H, Cerami A. Inhibitionof heparin-catalyzed human antithrombin Ⅲ activityby nonenzymatic glycosylation. Possiblerole in fibrin deposition in diabetes. Diabetes.1984;33:532-5.

26

26. Tilton RG, Chang K, Nyengaard JR, Van denEnden M, Ido Y, Williamson JR. Inhibition of sorbitol dehydrogenase. Effects on vascular andneural dysfunction in streptozotocin induced diabeticrats. Diabetes. 1995;44:234-42.

27

27. Nagamatsu M, Nickander KK, Schmelzer JD,Raya A, Wittrock DA, Tritschler H, et al. Lipoicacid improves nerve blood flow, reduces oxidativestress, and improves distal nerve conductionin experimental diabetic neuropathy. DiabetesCare. 1995;18:1160-7.

28

28. Karasu C, Dewhurst M, Stevens EJ, TomlinsonDR. Effects of antioxidant treatment on sciaticnerve dysfunction in streptozotocin-diabetic rats;comparison with essential fatty acids.Diabetologia. 1995;38:129-134.

29

29. Hotta N, Koh N, Sakakibara F, Nakamura J,Hamada Y, Wakao T, et al. Prevention of abnormalitiesin motor nerve conduction and nervebloodflow by a prostacyclin analog, beraprost sodium,in streptozotocin-induced diabetic rats.Prostaglandins. 1995;49:339-49.

30

30. Cameron NE, Cotter MA. Metabolic and vascularfactors in the pathogenesis of diabeticneuropathy. Diabetes. 1997;2:S31-7.

31

31. Hounsom L, Horrobin DF, Tritschler H, CorderR, Tomlinson DR. A lipoic acid-gamma linolenicacid conjugate ie effective against multiple indicesog experimental diabetic neuropathy.Diabetologia. 1998;41:839-43.

32

32. A society for the research of Neuropathy inKorean Diabetes Association. Clinical practice ofdiabetic neuropathy. 2nd ed. Seoul: KoreanDiabetes Association. 2007:1-48.

33

33. Doo HK. Internal medicine of kidney in orientalmedicine. Seoul :Institute of oriental medicine.1991:969-76.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine